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1. Introduction 
Keratitis infections caused by bacteria, fungus or Acanthamoeba may be the most important 
reason for visual loss after trachoma and xerophtalmia in undeveloped and developed 
countries. Wilhelmus KR. 1998. 
Early diagnosis and the availability of the powerful antibiotics give the opportunity of 
having a better control of the corneal infectious processes, mainly in those of bacteriological 
etiology. 
However, the virulence and resistance of some bacteria Hill JC et al 1986, fungi Polack FM et 
al 1971 and Acanthamoeba Blackman HJ 1984 may progress inexorably despite the maximum 
therapy applied and in those cases the integrity of the ocular globe will be jeopardized and 
then, it will be necessary to realize a penetrating keratoplasty, by removing, totally of 
partially, the infectious area in the cornea in the levels where the antibiotics and defense 
mechanisms of the guest, might be effective. 
The tectonic and therapeutic keratoplasty constitute a significant percentage of corneal 
transplants held in Asia and in some other under developed cities. In Singapore, it was 
reported a survey in which 13% of all transplants were with therapeutic or tectonic 
indication Tan DT, Janardhanan P 2008. 
 In Mexico, it was reported, in a 10 year-period, from 2001 thru 2010, out of the 3240 
transplants carried out in the Hospital for the prevention of Blindness, “Asociación para 
Evitar la Ceguera en Mexico, IAP” Mexico City had a tectonic or therapeutic indication. If 
we divide the therapeutic indication from the tectonic, the percentage lows down to 2.06% 
2. Indications 
The therapeutic keratoplasty is a surgical procedure whose indications include the following 
circumstances:  
a. To solve an infectious keratitis or a maximum conventional refractory inflammatory 
treatment.  
b. To reestablish the integral structure of the ocular globe because of the risk of sclera 
extension, descematocele or corneal perforation (tectonic keratoplasty). In some cases, 
both situations occur. 
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The Therapeutic keratoplasty is an emergency in which the integrity of the ocular globe is at 
risk, contrary to the optical keratoplasty where the visual rehab is indicated after the process 
is already controlled. 
Infectious keratitis present different clinical characteristics and history, depending on its 
etiology: therefore, the situations which require a penetrating keratoplasty are different 
from the bacterial micotic keratitis or for the Acanthamoeba. 
2.1 Bacterial keratitis 
The impact of bacterial keratitis on corneal blindness for scars, or other ocular complications 
is very important. In undeveloping countries for traumas risk, or in developed coutries in 
contact lens users, bacterial keratitis is a leading cause of corneal blindness.  
Probably, the first indication for therapeutic keratoplasty, within the perforated corneal 
ulcers whose etiological agent is Psedomonas aeruginosa, especially in tropical climates, in 
contact lens users and in hospitalized or weak patients. 
Psedomonas aeruginosa typically present as a rapidly evolving suppurative stromal infiltrate 
with marked mucopurulent exudate and become to corneal perforation in 24 to 48 hours 
because P aeruginosa due to colagenase production causing an important corneal stroma 
loss.  Therapeutic keratoplasty is required too in corneal ulcers caused by others Gram 
negative bacteria as Enterobacter, Serratia, klebsiella and Escherichia that contaminate contact 
lens and cause a severe corneal desepitelization and ulcers with a great damage of corneal 
stroma with marked mucopurulent exudate frequently with similar characteristics of 
progressive suppurative keratitis. Fig 1,2  
According to a survey published in 2007 by Ti et al, out of a revision of 92 patients (1991 to 
2002) with acute infectious Keratitis in Singapore National Eye Centre, reported the 
Pseudomonas aeruginosa as the main etiological agent, responsible for the keratitis requiring 
therapeutic keratoplasty. 
 
 
Fig. 1. Corneal ulcer caused by Gram negative, with perforation and poor response to 
medical treatment. 
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Fig. 2. The same eye 4 weecks after therapeutic sclerokeratoplasty (Courtesy of Alfredo 
Gomez Leal,MD  Phathology Service of “Asociacion para Evitar la Ceguera en Mexico 
Hospital “Dr. Luis Sanchez Bulnes”) 
Other bacterial keratitis that might require a therapeutic keratoplasty are those infections 
that do not reply to a medical treatment, whose etiological agents grow slowly and behave 
as opportunists and sluggish and that continue to grow despite the aggressive treatment 
including crystalline keratopathy caused by alphahemolytic Streptococcus Stern GA 1993 The 
concomitant corneal ulcers are a sequence of severe gonococcal conjunctivitis Kawashima M 
et al 2009 and the ulcer caused atypical mycobacterium, an opportunist pathogen that 
produce lesions in areas where local resistance is compromised by trauma or prior surgery.  
Clinically, non-tuberculous Mycobacteria cause slow-progressing keratitis, which may mimic 
the indolent course of disease caused by others organism as fungi or anaerobic bacteria and 
frequently an delayed diagnosis progress to a severe keratitis Perez-Balbuena et al, 2010. 
Figs. 3, 4, 5  
 
 
Fig. 3. Mycobacterium chelonae Keratitis. At initial examination, 4 weeks after penetrating 
keratoplasty with corneal infiltrates (3.0 X 2.0 mm) withe –gray with irregular and elevated 
edges in the donor-receptor interface. 
www.intechopen.com
 Keratoplasties – Surgical Techniques and Complications 
 
14
 
Fig. 4. Successful therapy 2 months with after topical  Gatifloxacin 0.3% therapy. 
 
 
Fig. 5. Eighteen months after therapy discontinuation, corneal graft is infection–free and 
clear in the visual axis. 
Mycobacterium keratitis is frequently present after a surgical procedure like refractive 
surgery (LASIK) with a slow progression to need a flap amputation or a therapeutic 
keratoplasty Susiyanti M, et al 2007.  
Critical corneal infections occasionally requires conjunctival flap or therapeutic keratoplasty, 
in USA eye banking statistics identify microbial keratitis as a reason for keratoplasty in 1% 
of all corneal transplantation and in relation to bacterial keratitis incidence approximately 
1% of USA cases of corneal infections become surgical candidates. Wilhelmus KR. 1998 
In the experience obtained at the cornea service of “Dr. Luis Sánchez Bulnes” Hospital in 
Mexico, reported 2025 cases of infectious keratitis (survey carried out by fellow Carlos 
Johnson Villalobos MD. In a period from 2001 thru 2010, the causative agents were Gram 
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positive bacteria in 67.2% cases, Gram negative bacteria in 14.91%, and fungal keratitis in 
6.81% cases; In my Service, I found in 3240 keratoplasties from 2000-2010, 3.30% patients 
needed therapeutic keratoplasty. Figs. 6, 7 
 
 
Fig. 6. Fungal keratitis (fusarium solani) 4 weeks evolution. 
 
 
Fig. 7. Septated hyphal cells from Fusarium solani (Schiff stain 100X) 
With the upcoming of new and more powerful antibiotics (fourth generation quinolones), 
the therapeutic keratoplasty is less frequently required for keratitis caused by Gram positive 
bacteria Al-Shehn et al. 2009, highlighted this over a 10-year period (1995-2005). They noted 
significant improvement in percentage of eyes achieving microbiological cure with medical 
therapy alone (76.0% in 1995 vs. 92.2% in 2005; p=0.002) or combining with surgical 
intervention (92.4% in 1995 vs. 100.0% in 2005; p=0.005). 
2.2 Fungal keratitis 
The therapeutic keratoplasty has an important role in the refractory mycotic ulcers 
treatment. In a series published by Ibrahim MM et al in 2009 in Brasil, 66 patients with 
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mycotic ulcer, therapeutic keratoplasty was required in 38% of cases; the most frequent 
isolated etiological agent was Fusarium in 67%, Aspergillus 10.5% and Candida 10%. 
In several studies published by Perez-Balbuena et al. 2009, Vanzzini et al. 2010, the main 
fungal pathogens for keratitis in Mexico are Fusarium solani and other species, dematiaceous 
fungus that include a wide group of black colony forming fungus and Aspegillus with 
several species too. 
 
 
Fig. 8. Fusarium large corneal ulcer 10 days after injury with organic material. 
 
 
Fig. 9. Successful postoperative the same eye outcome six months after therapeutic 
keratoplasty loose suture after surgery 
In a retrospective survey carried out from 1981 to 2001 in the Cornea Service of “Asociacion 
para Evitar la Ceguera en Mexico Hospital “Dr. Luis Sanchez Bulnes”, we studied 120 cases 
of mycotic keratitis selecting 61 cases whose etiological agent was Fusarium solani, confirmed 
by the cultures. In total, 78% were male (average, age, 41.5 years) the principal risk factor 
was ocular trauma contaminated with organic material, dry eye, post corneal surgery in 
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infections and Candida albicans in contact lens user, and the patient came to be examined 2 to 
6 weeks after the trauma.  
The ulcers observed were indolent, with satellite lessons in 30% patients, irregular edges, 
dense infiltrate and hypopyon, ciliary injection in conjunctiva, Figs .8, 9, 10, 11 usually 
treated before with antibacterial drops without clinical healing.  
 
 
Fig. 10. Hyphal elements visible on pathologic examination of corneal button. Schiff stain 
(20X magnification). 
 
 
Fig. 11. Septate hyphal fungus cells in the corneal scrap smears of fungal keratitis patients, 
stained with calcofluor (Cellfluor) and fluorescens microscopy ( 20X magnification) 
The antifungal treatments were started immediately after the diagnosis was confirmed in 
each case. The total 81% of patients were treated with monotherapy and 18.4% patients with 
combined antifungal therapy. As antifungal therapy, 2% ketoconazole suspensión was 
prepared using 200 mg tablets (Nizoral®, Janssen Cilag, Mèxico City), manually crushed to 
fine poder and suspended in hidroxypropylmethyl-cellulose eye drops. A total of 14 of 27 
(51.2%) cases also received oral ketoconazole 200-400 mg every 24 hours. Nine patients were 
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treated with topical itraconazole 1.0% drops (Sporanox®, Janssen-Cilag, Mèxico City) made 
in the same way as ketoconazole. Perez-Balbuena et al. 2009 
The Fluconazole (2mg/ml Diflucan®, Pfizer) topical drops were made with intravenous 
solution of 2 mg/mL with <1mg/mL (0.66 mg) in final concentration using 
hidroxypropylmethyl-cellulose eye drops. 
Severe cases were assigned to the medical and surgical treatment, using either monotherapy 
or combined topical antifungal treatment plus one or more surgeries. Therapeutic 
keratoplasty was indicated in 14/61 patients 23%. Conjuntival flap was indicated en 4 of 61 
patients 6.5%, eviscearation surgeries were practiced in 14 of 61 patients 22.9%. 
For medical treatment actually we use Natamycin 5% suspension in ocular droops 
(Miconacina® Grin laboratorios Mexico City) each 1 hour initially for two days, and after 
each 4 hours for 8 to 15 days upon the clinical response, we use this last dosage at least for 
30 to 40 days, in cases of Aspergillus keratitis the medication mentioned before is associated 
with oral Itraconazole 100 mgs/ 12 hours. For Candida keratitis we use topical Voriconazole 
1% (V-Fend® Pfizer Germany)) or Fluconazole 1% (Diflucan® Pfizer Germany). The 
indications for therapeutic keratoplasty included minimun improvement with medical 
therapy or high perforation risk. Table 1 
 
Medical / Surgical Therapy group 
Drug n 
Conjuncti-
val Flap 
Penetrating
kerato-
plasty 
Tectonic 
kerato-
plasty 
Eviscera-
tions 
Tome of 
Treatment 
Days 
Natamycin 0 0 0 0 0 0 
ketoconazole 11 0 4 1 7 20.6 
Miconazole 0 0 0 0 0 0 
Itraconazole 3 2 2 1 2 26 
Fluconazole 1 1 0 0 1 40 
Ketoconazole+Natamicycin 
+Fluconazol 
1 0 1 0 0 15 
Ketoconazole+Itraconazole 1 0 1 0 0 20 
Ketoconazole+Fluconazole 3 0 1 0 2 78.3 
Itraconazole+ Fluconazole 2 0 2 0 0 47 
Natamycin+ Fluconazole 1 1 1 0 0 170 
Ketoconazole+ Miconazole 1 0 0 0 1 20 
No treatment and lost follow-up 4 0 3 0 1 0 
Total 28 4 15 2 14  
Table 1. Antifungal therapy used in the medical and surgery group 
Killingsworth et al. 1993 obtained a 100% recovery in 15 ulcers treated with therapeutic 
Keratoplasty. We suggested surgical therapy with conjunctive flap or penetrating 
keratoplasty in advanced cases when there has been a poor response to medical therapy or a 
very low final visual acuity. 
2.3 Acanthamoeba keratitis 
The ophthalmic pathology caused by Acanthamoeba might produce severe and extensive 
corneal necrosis that tome times require therapeutic keratoplasty. The evolution of an 
infection becomes in a severe stromal keratitis of late diagnosis, inadequate treatment and 
severe consequences.  
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Patient with acanthamoebic keratitis are tipically young, healthy individuals, males or 
females are equally affected, almost all are daily contact lens wearer, or using non sterile 
wather for wash the contact lenses, is most frequently is an unilateral keratitis but bilateral 
cases have ocurred. The most important clinical sign is a severe pain even with a small 
epithelial dendritiform ulcer because the recurrent epithelial breakdown like an herpetic 
ulcer in the early stages of the infection. Some patients have a stage of disease mimicking 
disciform stromal keratitis and others develop radial neuritis. The occurrence of satellite 
lesions, stromal abscess, necrotizing inflammation, hypopyon, scleral nodules, diffuse 
scleritis or posterior scleral inflammation are signals of advanced infection. Figs. 12, 13 The 
most characteristic stromal antigen-antibody inflammatory reaction is the stromal ring 
formation that can consist of single, multiple or overlapping rings around the main corneal 
ulcer. Alizadeh H, et al 1998  
The ophthalmic pathology caused by Acanthamoeba might produce severe and extensive 
corneal necrosis that tome times require therapeutic keratoplasty. The evolution of an 
infection becomes in a severe stromal keratitis of late diagnosis, inadequate treatment and 
severe consequences. Despite is rare pathology, in the last decade are incremented its 
frequency, associated to contact Lents user. Ficker LA et al 1993. 
Before carrying out a therapeutic keratoplasty it is important to give a medical therapy and 
many drugs have been tested for Acanthamoeba infections as mentioned in the Box No 1, the 
most used are Chlorexidine 0.01% in aqueous solution not commercially available, 
Polimethylene biguanide 0.3% in aqueous solution (Brolene® UK). Oral Itraconazole 100 
mgs/ 12 hours combined with topical Netilmycin 0.3% (Netira® SCIFI laboratories Italy) are 
actually used in our acanthamoebic keratitis patient.  
 
 
Fig. 12. Acanthamoeba keratitis in young and healthy female patient, 6 weeks evolution time, 
edema, and central ulcer.  
Laboratory diagnosis are better done by visualizing cyst cells in the mucous exudate or in 
corneal biopsies, by stain tecniques like Giemsa Fig. 13 or Calcofluor (Cellfluor)  and 
fluorescence ligth microscopy and by cultures C in non nutrient Pages medium with a layer 
of inactivated cells of Enterobacter aerogenes.  
www.intechopen.com
 Keratoplasties – Surgical Techniques and Complications 
 
20
 
Fig. 13. Acanthamoeba cyst Giemsa stein, in light microscope view (20 X magnification) 
Before carrying out therapeutic keratoplasty it is important to give a medical therapy and 
many drugs have been tested for Acanthamoeba infections as mentioned in the , the most 
used are Chlorexidine 0.01% in aqueous solution not commercially available, Polimethylene 
biguanide 0.3% in aqueous solution (Brolene ®UK) we used in our  
Oral Itraconazole 100 mgs/ 12 hours combined with topical Netilmycin 0.3% (Netira® SCIFI 
laboratories Italy) are actually used in our acanthamoebic keratitis patient. Medical and 
surgical treatment in Keratitis by Acanthamoeba is controversial. 
In some cases with early diagnosis these cases have been successfully treated with medical 
treatment without being necessary to undergo a surgical procedure of therapeutic 
keratoplasty. Ficker et al 1993, mention that the over life of the graft by Keratitis by 
Acanthamoeba is of poor outcome, reporting more than 50% recurrence incidence of the graft. 
However, in our personal opinion, the Keratoplasty continues to have a central role in the 
management of patients who progress or do not respond to medical treatment. The acute 
management of these active cases is to sterilize the infection as rapidly as posible and to 
dalay surgical management until the patient receives adequate antiamebic therapy.  
3. Pre-surgical evaluation 
When the decision has been taken to perform a therapeutic Keratoplasty, a good 
examination is necessary to value the following points. 
To evaluate the size, depth and place of the infiltrate or corneal ulcer, if the limbos is 
compromised, or if there is imminent or actual perforation. 
To evaluate the posterior pole under dilation, if it is possible, specially the vitreo retinal 
area, and when it is not possible we must realize a B Scan ultrasound and if the integrity of 
the ocular globe is affected by an imminent perforation it is necessary to make a Trans 
palpebral ecography to evaluate a probable endophtalmitis. Increased risk for 
endophthalmitis at the time of therapeutic keratoplasty includes the presence of fungal 
disease, corneal perforation and patients who have undergone previous cataract extraction.  
To evaluate the presence of cataract and to carefully decide the extraction of the crystalline 
since this is a barrier to avoid the extension of the infectious process toward the posterior 
pole. It is recommended to try to keep the posterior capsule to diminish the risk of 
Endophthalmitis. SpeakerMG et al 1991. 
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Before surgery, intraocular pressure should be evaluated in eyes without a perforation. 
Adequate pressure control remains essential. In patients with markedly elevated intraocular 
pressure or in patients with a corneal perforation in which the lens-iris-diaphragm has 
moved forward, we give intravenous manitol to control intraocular pressure and to reduce 
the vitreous volume. 
In eyes with a crystalline lens or posterior chamber intraocular lens, and patients with iris 
incarcerated in a wound, we give Pilocarpina 2% 1 hour prior to surgery, to protect the lens, 
and maintain a posterior lens-iris diaphragm. 
We do not recommend carrying out the surgery with local anesthesia, it is much better to 
perform it under general anesthesia and in all cases we must maintain the arterial pressure 
under control to reduce the risk of expulsive choroidal hemorrhage, especially in those 
patients with perforation. 
4. Preoperative treatment 
Before therapeutic keratoplasty for infectious keratitis, the patient should be treated with 
topical and systemic therapy directed towards the offending microbe. This treatment applies 
to bacterial, fungal and Acanthamoeba. 
Regardless of the infectious etiologies, we always recommend topical antbiotic therapy to 
prevent bacterial super infection. 
The preoperative antibiotic prophylaxis should be broad spectrum and nontoxic to help 
promote reepithelization and prefer an antibiotic that penetrates into the cornea, aqueous 
achieve levels above to MIC90   of most pathogenic bacteria. 
We currently use a topical fourth –generation fluoroquinolone Gatifloxacin 0.3% (ZymarR; 
Allergan Inc, Irvine, CA) with a saturating dosage of one drop every 15 minutes for 1 hour 
before keratoplasty. 
5. Donor material 
Criteria for the selection of donor corneas are stringent, except in cases of large perforation 
when access to tissue of optimal quality is not possible. Corneal tissue of excellent grade 
offers the following advantages:  
5.1. Healthy tissue with intact epithelium minimizes the risk of re infection in the graft and 
use of healthy endothelium is critical for the survival of the graft. 
5.2. Compact and clear tissue helps in monitoring anterior chamber reaction during the 
immediate postoperative period. 
Yao et al. 2003. If fresh donor tissue is not available, the use of cryopreserved tissue and 
donor corneas preserved in pure glycerin or water-free calcium chloride are effective 
substitutes in therapeutic keratoplasty to control severe fungal corneal infection and 
preserve the global integrity. 
6. Surgical techniques 
Although corneal transplantation for infections keratitis follows the basic surgical technique 
of penetrating keratoplasty, special attention must be given to certain details: 
6.1 Preoperative procedures 
We recommend general anesthesia .It is important to have a soft eye preoperatively so that 
problems related to positive vitreous pressure can be prevented. 
www.intechopen.com
 Keratoplasties – Surgical Techniques and Complications 
 
22
Intravenous Manitol produces deturgescence of the vitreous and helps to minimize these 
problems. 
At the time of therapeutic keratoplasty by placing the appropriate trephine over the cornea 
and creating an indentation in the epithelium. 
6.2 Exposure 
In general, we commonly use lid speculum and suture a Fleringa ring in place to provide 
scleral support, in cases of large ulcers that reach up to the limbus, peritomy is required and 
homeostasis is achieved by the use of wet-field cautery. 
6.3 Host preparation bed 
The goal of surgery is to excise all necrotic or infected tissue during trephination. It possible, 
a 1 mm rim of healthy corneal tissue should also be removed to leave a stable, no infected 
recipient bed. 
Conjuntival peritomies should be done in cases requiring large or eccentric grafts. 
The trephination of the recipient bed can be technically difficult. Careful partial-thickness 
trephination with a Sharp trephine is done in the absence of any perforation; in eyes with a 
perforation, support is obtained with cyanocrylate and viscoelastic protection and anterior 
chamber can be reformed and the host trephination can be performed under a more controlled 
environment, care should be taken to avoid exerting excessive pressure on the globe to prevent 
extrusion of the ocular contents a freehand dissection of the host bed may be done. 
6.4 Clearing the anterior chamber of exudates 
Irrigation of the anterior chamber is done using a balanced salt solution. Elimination of all 
exudative material from the anterior chamber helps to prevent the recurrence of infection 
and reduces complications such as glaucoma.  
The membranes over iris are dissected gently by the irrigating cannula and are removed 
with forceps. Any membrane covering the iris surface should be removed very gently, and 
every effort should be made to arrest bleeding from the iris surface. 
Intracameral antibiotics or antifungals can be used whenever they are required. 
Two large peripheral iridectomies are recommended .Removal of cataracts should be 
deferred because the lens forms an effective barrier that prevents the spread of infection into 
the vitreous. When vitreous involvement is diagnosed, open sky vitrectomy is indicated. 
The anterior chamber is reformed with a viscoelastic substance, and the margin of the 
recipient bed is trimmed. 
6.5 Preparation of the donor botton 
The donor button should be trephined after the size of the recipient opening is measured 
and preparation of the host bed, because necrotic tissue may require additional trimming 
which may alter the size of the graft.  
The donor button is punched from the endothelial side and usually 0.5-1.0 mm larger than 
the selected host trephine. 
6.6 Suturing 
The donor-recipient junction was sewn by 10-0 monofilament Nylon interrupted sutures 
passing though at least 70% depth of the host cornea is the preferred technique. Full 
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thickness bites are not taken as they may form a conduit for passage of infection from the 
cornea into the anterior chamber. It is not uncommon to use greater number of sutures than 
conventional technique of keratoplasty (16 Sutures).Table 2 
 
Age 50,90 ± 16,298 years old 
Sex 68,7 % (♂) 
Type penetrating keratoplasty  98.5% QPP vs.1.5% Lamelar  
Endophthalmitis 11,9 %  
Perforation 50,7 %  
Survival graft 10,08 ± 15,97 months 
Size of the donor 8,80 ± 0,19 mm. 
Size receiver  8,17 ± 0,13 mm. 
Table 2. Profile of infectious keratitis 2025 cases, during 10 years (2000-2010) in 14.65% cases 
with therapeutic keratoplasty in advanced process, dates of “Asociación Para Evitar la 
Ceguera en México Hospital “Dr. Luis Sanchez Bulnes” 
7. Postoperative management 
Immediate postoperative treatment focuses on prevention of recurrence of infection and 
hastening the complete epithelization of the graft. 
 
 
Box 1. Guidelines for postoperative management of terapeutic keratoplasty 
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Appropriate antimicrobial therapy must be continued postoperatively until the corneal 
epithelium has healed  
The general guidelines for postoperative management are shown in (Box 1). Therapy may 
be guided by histopathological and microbiological evaluation of the excised corneal 
tissue. 
8. Complication 
Postoperative complications after therapuetic keratoplasty are virtually the same as in other 
situations, except the prevalence is greater.  
Depending on the time of onset, complications can be divided in early- onset complications 
(within 2 weeks) and late-onset complications. The early postoperative period may be 
complicated with wound leak, shallow anterior chamber, hyphema, anterior uveitis, 
elevated intraocular pressure, persistent epithelial defect and re- infection of the graft. Late 
postoperative complications include cataract, glaucoma, graft failure secondary to rejection, 
infection or endothelial decompensation and phthisis bulbi. Table 3 
 
COMPLICATION % 
Corneal Decompesation/ primary failure 37.31 
Recidive 31.34 
Persistent epithelial defect 23.88 
Glaucoma 22.38 
Refractory to treatment reyect 7.46 
Cataract 7.46 
Ptisis bulbi 2.98 
Corneal melting 4.47 
Seidel 1.49 
Retinal detachment or DC 1.49 
Cellulitis orbitaria 1.49 
Primary failure 26.66 
Corneal decompensation 
Flat anterior chamber 
10.44 
1.70 
Table 3. Therapeutic keratoplasty Complications of infectious keratitis 2025 cases, during 10 
years (2000-2010) in 14.65% cases with therapeutic keratoplasty in advanced process, dates 
of “Asociación Para Evitar la Ceguera en México Hospital “Dr. Luis Sanchez Bulnes”, some 
patient had one or two complications. 
8.1 Early-onset complications 
8.1.1 Seidel 
This is an avoidable complication if the surgical technique is careful and the wound is well 
constructed The best way to prevent wound leaks is to ensure meticulous wound apposition 
at the end of the procedure. Promptly resuturing is recommended if non surgical attempts 
like patching or contact lens bandage fail to seal the leak. Prolonged contact between the 
donor cornea and the iris, lens, or IOL may result in irreversible complications and sequel. 
In our experience resuture was needed in 1, 49% of therapeutic keratoplasty.  
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8.1.2 Shallow or flat anterior chamber 
This is a generally avoidable complication with a watertight wound. At the end of the 
surgery is critical that we ensure the integrity of the wound. Shallow or flat anterior 
chamber if present, should be managed as soon as possible to avoid synechiae formation 
which may result in irreversible endothelial cell loss and consequently early graft failure. In 
our center we needed to reform the anterior chamber either with BSS or with viscoelastic 
substances in 1, 7 % of the cases. 
  
 
Fig. 14. Flat anterior chamber in this patient with synechiae formation post therapeutic 
keratoplasty 
8.1.3 Hyphema 
Surgical trauma on an eye with vessels on the surface of the iris or in the cornea can cause 
hyphema. Every effort should be done to prevent bleeding from the iris surface. Slight 
bleeding usually stops spontaneously with closure of the eye and return of adequate IOP. If 
the hemorrhage persists in the presence of an adequate IOP, then it may need to be 
 
 
Fig. 15. Fibrine and hyphema 48 hours post keratoplasty in severe fungal ulcer (Aspergillus 
flavus) 
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Controlled using cautery, compression with viscoelastic, or tamponade with sponges soaked 
with epinephrine 1:1000. If hyphema is persistent and provokes a rise in intraocular 
pressure, it should be immediately evacuated. Fig. 15 
8.1.4 Anterior uveitis 
Infectious keratitis itself explains the great inflammation that is seen after PK in these 
patients. The risk of severe postoperative inflammation can be diminished by gentle 
manipulation during surgery and the meticulous removal of all inflammatory material of 
the anterior chamber. The aggressive control of postoperative inflammation is also essential 
for the prevention of synechiae formation. Usually the uveitis is solved with the aid of 
cicloplegic and corticosteroid drugs, but the latter should be used with caution in fungal and 
Acanthamoeba keratitis. 
 
 
Fig. 16. Corneal ulcer by Aspergillus flavus ,three days Post- keratoplasty  
8.1.5 Ocular hypertension 
Severe inflammation causes trabeculitis and this causes elevation of the intraocular pressure. 
Besides peripheral anterior synechiae if present and not broken during surgery can impeed 
aqueous outflow and cause secondary glaucoma. Usually elevation of intraocular pressure 
can be controlled with beta blockers and systemic acetazolamide while the inflammation 
diminishes. 
8.1.6 Persistent epithelial defect 
Careful handling of the donor cornea intraoperatively is imperative to avoid damaging the 
epithelium. Good wound apposition and prevention of an overriding edge leads to better 
tear-film distribution and a reduced incidence of epithelial defects. A persistent epithelial 
defect has the potential to secondary infection thus reepithelialization and the maintenance 
of an intact epithelium is critical for postoperative wound healing, graft survival, and 
protection against infection and melting. Initial treatment requires application of topical 
lubricants and if it persists a permanent or temporary tarsorrhaphy early in the 
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postoperative period can be performed. Alternatively, botulinum A toxin injected into the 
elevator muscle to induce a complete ptosis, may help reduce the severity and persistence of 
an epithelial defect. 
The use of preservative-free medication is recommended to reduce the risk of epithelial 
toxicity and corticosteroids may need to be decreased.  
8.1.7 Recurrence 
The indiscriminate use of corticosteroids postoperatively can cause recurrence of the infection, 
especially in micotic keratitis. In our experience we report recurrence in 31, 4%, being the most 
frequent cause fungal keratitis, as Rao et al 1999 reported. 50% of these recurrences needed a 
new PK to be free of infection. Time of recurrence varied between 1-42 days. 
 
 
Fig. 17. Therapeutic keratoplasty, Mycobacterium chelonae corneal ulceration 30 Days post 
LASIK 
 
 
Fig. 18. Same eye showing recurrence of infection (Mycobacterium chelonae) Involving the 
entire graft 
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Recurrences can be avoided by performing a careful excision of the recipient cornea 
including all the infected material and with as adequate postoperative antibiotic and 
corticosteroid management. In our experience in fungal keratitis an Non tuberculous 
Mycobacterium we observed 31.34% recurrences. Fig. 17,18. 
8.2 Late-onset complications 
8.2.1 Secondary glaucoma 
Adequate control of postoperative inflammation and careful liberation of synechiae during 
surgery lowers the incidence of secondary glaucoma which can endangers keratoplasty 
success. We found a incidence of secondary glaucoma of 22,4%. Only 4, 47% patients needed 
a filtering surgery to control intraocular pressure. Fig. 19. 
 
 
Fig. 19. Some patient needed Ahmed valvule for hypertension control 
8.2.2 Cataract 
As lens metabolism is dependent on the health of the eye, any ocular disease that affects the 
supply of oxygen and nutrients, or produces toxic substances will give rise to cataract. Also 
the incidence of cataract formation is higher because of the intense postoperative steroid 
treatment. We did find an incidence of 7, 46%. 
8.2.3 Graft failure 
Graft failure can be secondary to unresponding to treatment graft reject, endothelial 
descompensation or infection recurrence. It is much more common in therapeutic 
keratoplasties than in other indications. We report an incidence of 38,8%. In our center is 
much higher than in other reports because the quality of donor tissue in this type of 
keratoplasty is not as good as in optical procedures because of the relative paucity of corneal 
tissue in our country as well as the emergency under which this surgery is performed. 
Sharma et al. 2010 After the integrity of the globe is preserved and ocular inflammation has 
subsided, a smaller-diameter optical keratoplasty may be performed electively for visual 
rehabilitation 
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Fig. 20. Post Therapeutic keratoplasty in Candida keratitis, with clear button and cataract. 
8.2.4 Phthisis bulbi 
Severe inflammation causes if left untreated, can cause great alteration and disorganization 
of intraocular structures and atrophia. Despite all efforts to maintain globe integrity we still 
can find phthisis in 2, 98% of the therapeutic keratoplasties.  
9. Conclusion 
Therapeutic keratoplasty is generally an emergency, high-risk procedure that challenges the 
surgical and medical skills of the corneal surgeon. It requires meticulous attention to detail 
and careful postoperative monitoring. Therapeutic keratoplasty play a definitive role in the 
treatment of microbial keratitis refractory to medical therapy. Advances in microsurgical 
technique, antimicrobial therapy new and more powerful antibiotics (fourth generation 
quinolones), and control of inflammation have resulted in an improved prognosis for 
therapeutic keratoplasty in cure and improved visual outcomes. 
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